Angel Physicians Fund — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

MuRevamurevapt.comDec 2018

MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy.

Advanced ManufacturingHardwareHealthtechMedical DevicesBrecksville, US

Peter Broer(Director)Vedang Phototherapy Kothari(Executive Officer)Creighton Murch(Director)Austin Ruhle(Chief Financial Officer)Vedang Kothari(President)Sam Shelnutt(Vice-President of Engineering)

Co-investorsBand of Angels Jumpstart Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.